These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 34474088

  • 1. Variation in Pharmacologic Management of Patients with Kawasaki Disease with Coronary Artery Aneurysms.
    Selamet Tierney ES, Runeckles K, Tremoulet AH, Dahdah N, Portman MA, Mackie AS, Harahsheh AS, Lang SM, Choueiter NF, Li JS, Manlhiot C, Low T, Mathew M, Friedman KG, Raghuveer G, Norozi K, Szmuszkovicz JR, McCrindle BW, International Kawasaki Disease Registry.
    J Pediatr; 2022 Jan; 240():164-170.e1. PubMed ID: 34474088
    [Abstract] [Full Text] [Related]

  • 2. Aspirin Dose in Kawasaki Disease: The Ongoing Battle.
    Dhanrajani A, Chan M, Pau S, Ellsworth J, Petty R, Guzman J.
    Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1536-1540. PubMed ID: 29287309
    [Abstract] [Full Text] [Related]

  • 3. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
    Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW.
    J Am Heart Assoc; 2016 Sep 15; 5(9):. PubMed ID: 27633390
    [Abstract] [Full Text] [Related]

  • 4. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
    Turk J Pediatr; 2019 Sep 15; 61(5):648-656. PubMed ID: 32104995
    [Abstract] [Full Text] [Related]

  • 5. Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin.
    Matsuoka R, Furuno K, Nanishi E, Onoyama S, Nagata H, Yamamura K, Sugitani Y, Kuraoka A, Mizuno Y, Sagawa K, Honjo S, Hara T, Ohga S.
    J Pediatr; 2020 Dec 15; 227():224-230.e3. PubMed ID: 32810506
    [Abstract] [Full Text] [Related]

  • 6. Correlation of Coronary Artery Abnormalities with Fever Pattern in Patients with Kawasaki Disease.
    Tanaka A, Inoue M, Hoshina T, Koga H.
    J Pediatr; 2021 Sep 15; 236():95-100. PubMed ID: 34019881
    [Abstract] [Full Text] [Related]

  • 7. Extensive coronary aneurysms with thrombosis in resistant Kawasaki disease.
    Sivakumar K, Pavithran S.
    Pediatr Cardiol; 2013 Feb 15; 34(2):444-6. PubMed ID: 22427313
    [Abstract] [Full Text] [Related]

  • 8. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec 15; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 9. Kawasaki disease: Medical therapies.
    Newburger JW.
    Congenit Heart Dis; 2017 Sep 15; 12(5):641-643. PubMed ID: 28580631
    [Abstract] [Full Text] [Related]

  • 10. Multiple giant succular and fusiform right and left coronary artery aneurysms after early and adequate treatment of atypical kawasaki disease with unusual presentation.
    Behjati-Ardakani M, Ferdosian F.
    Acta Med Iran; 2014 Sep 15; 52(6):490-2. PubMed ID: 25130161
    [Abstract] [Full Text] [Related]

  • 11. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
    Iio K, Morikawa Y, Miyata K, Kaneko T, Misawa M, Yamagishi H, Miura M.
    J Pediatr; 2022 Jan 15; 240():158-163.e4. PubMed ID: 34461064
    [Abstract] [Full Text] [Related]

  • 12. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
    Eleftheriou D, Moraes YC, Purvis C, Pursell M, Morillas MM, Kahn R, Mossberg M, Kucera F, Tulloh R, Standing JF, Swallow V, McCormack R, Herberg J, Levin M, Wan M, Klein N, Connon R, Walker AS, Brogan P.
    Trials; 2023 Jan 26; 24(1):60. PubMed ID: 36703139
    [Abstract] [Full Text] [Related]

  • 13. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
    Friedman KG, Gauvreau K, Baker A, Son MB, Sundel R, Dionne A, Giorgio T, De Ferranti S, Newburger JW.
    Arch Dis Child; 2021 Mar 26; 106(3):247-252. PubMed ID: 32943389
    [Abstract] [Full Text] [Related]

  • 14. A girl with extremely refractory Kawasaki disease: an instructive case with unusual course and outcome.
    Kossiva L, Karanassios E, Papadopoulos G, Karavanaki K.
    Cardiol Young; 2012 Aug 26; 22(4):461-5. PubMed ID: 21933460
    [Abstract] [Full Text] [Related]

  • 15. Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis.
    Miyata K, Bainto EV, Sun X, Jain S, Dummer KB, Burns JC, Tremoulet AH.
    Arch Dis Child; 2023 Oct 26; 108(10):833-838. PubMed ID: 37258054
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
    Lancet Child Adolesc Health; 2018 Dec 26; 2(12):855-862. PubMed ID: 30337183
    [Abstract] [Full Text] [Related]

  • 17. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Dec 26; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 18. Management of acute and refractory Kawasaki disease.
    Tacke CE, Burgner D, Kuipers IM, Kuijpers TW.
    Expert Rev Anti Infect Ther; 2012 Oct 26; 10(10):1203-15. PubMed ID: 23199405
    [Abstract] [Full Text] [Related]

  • 19. Variation in the management of Kawasaki disease.
    Dionne A, Burgner D, De Ferranti S, Singh-Grewal D, Newburger J, Dahdah N.
    Arch Dis Child; 2020 Oct 26; 105(10):1004-1006. PubMed ID: 31196912
    [Abstract] [Full Text] [Related]

  • 20. Kawasaki disease with pulmonary nodules and coronary artery involvement: a report of two cases and a review of the literature.
    Akagi K, Abe J, Tanaka K, Tomotaki S, Iki Y, Ueda K, Nakata M, Yoshioka T, Shiota M, Hata A, Watanabe K, Hata D.
    Int J Rheum Dis; 2017 Nov 26; 20(11):1862-1864. PubMed ID: 26200440
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.